CJC-1295-DAC – 5mg [Growth Hormone Signaling + Recovery]
Supports sustained growth hormone signaling by increasing the duration and stability of endogenous GH release.
CJC-1295-DAC is a long-acting growth hormone–releasing hormone (GHRH) analog designed to extend the half-life of GHRH activity through Drug Affinity Complex (DAC) binding. It is widely studied in research settings focused on growth hormone dynamics, recovery processes, and metabolic regulation.
Key Research Areas:
• Sustained growth hormone signaling
• IGF-1 modulation and endocrine research
• Recovery and tissue maintenance pathways
• Metabolic and body composition research
Unlike non-DAC variants, CJC-1295-DAC is specifically researched for its prolonged activity profile, making it of interest in studies examining long-term GH stimulation and downstream biological effects.
Product Details:
• Compound: CJC-1295-DAC
• Quantity: 5mg
• Form: Lyophilized powder
• Packaging: Sterile sealed vial
• Certificate of Analysis: Available
Storage & Handling:
Store in a cool, dry environment. Refrigeration recommended after reconstitution. Avoid repeated freeze–thaw cycles.
Disclaimer:
Information is provided for educational and research reference only and is not medical advice. Products are intended solely for laboratory research use and are not for human or veterinary consumption. These products have not been evaluated by Health Canada, the FDA, or any regulatory authority. Purchasers assume responsibility for lawful handling and use.
Reviews
There are no reviews yet.